4//SEC Filing
Bressi Jerome Charles 4
Accession 0000950170-25-006310
CIK 0001434316other
Filed
Jan 15, 7:00 PM ET
Accepted
Jan 16, 6:31 PM ET
Size
7.2 KB
Accession
0000950170-25-006310
Insider Transaction Report
Form 4
Bressi Jerome Charles
See Remarks
Transactions
- Award
Common Stock
2025-01-15+65,000→ 335,203 total - Award
Stock Option (Right to Buy)
2025-01-15+250,000→ 250,000 totalExercise: $1.32Exp: 2035-01-14→ Common Stock (250,000 underlying)
Footnotes (2)
- [F1]Award of restricted stock units that vest with respect to 1/4th of the underlying shares on each of January 8, 2026, January 8, 2027, January 8, 2028 and January 8, 2029, subject to the Reporting Person's continued service with the Issuer as of each such vesting date.
- [F2]The shares subject to this option shall vest in 36 equal monthly installments following January 1, 2025, such that all of the shares shall be fully vested and exercisable on January 1, 2028, subject to the Reporting Person's continued service with the Issuer as of each such vesting date.
Documents
Issuer
FATE THERAPEUTICS INC
CIK 0001434316
Entity typeother
Related Parties
1- filerCIK 0002034505
Filing Metadata
- Form type
- 4
- Filed
- Jan 15, 7:00 PM ET
- Accepted
- Jan 16, 6:31 PM ET
- Size
- 7.2 KB